Alachua, Florida

Alachua, Florida

Our Alachua facility integrates cutting-edge technology to drive innovation and establish new standards in viral vector and nucleic acid analytics and manufacturing. Specifically designed to cater to advanced therapies, this facility is one of two dedicated sites solely focused on advancing cell and gene therapies through CDMO R&D and translational services. This dedicated approach not only enhances our advanced therapy CDMO services but also facilitates a seamless transition of products and processes from small-scale translational services to the stage of commercial manufacturing.

Key Features:

A 57,000-square-foot facility equipped for robust process and analytical R&D, dedicated to translational services and CDMO R&D for cell and gene therapies.

Specialized Capabilities:

  • Scalability from small-scale to 50L+ for designing and evaluating new technologies with commercial potential
  • Comprehensive Viral Vector R&D covering AAV, AdV, RV, HSV, and LV, utilizing both adherent and suspension platforms
  • Analytical testing for translational services
  • Cell line cloning and adaptation
  • Nucleic Acid R&D for plasmid and mRNA manufacturing and analytics


Alachua, Florida Site - Thermo Fisher Scientific

13859 Progress Blvd
Alachua, FL 32615
Phone: +1 386 418 8199